Reply - 27/11/13
Doi : 10.1016/j.jaci.2013.09.013
Simon G.A. Brown, MBBS, PhD, FACEM a, b 
, Shelley F. Stone, PhD a, Daniel M. Fatovich, MBBS, PhD, FACEM a, b, Geoffrey K. Isbister, MBBS, MD, FACEM c
, Shelley F. Stone, PhD a, Daniel M. Fatovich, MBBS, PhD, FACEM a, b, Geoffrey K. Isbister, MBBS, MD, FACEM c a Centre for Clinical Research in Emergency Medicine, Western Australian Institute for Medical Research and the University of Western Australia, Perth, Australia
b Department of Emergency Medicine, University of Western Australia, Royal Perth Hospital, Perth, Australia
c Department of Clinical Toxicology and Pharmacology, Calvary Mater Hospital and the Discipline of Clinical Pharmacology, University of Newcastle, Newcastle, New South Wales, Australia
Il testo completo di questo articolo è disponibile in PDF.
| Disclosure of potential conflict of interest: S. Brown has received grants from the National Health and Medical Research Council, the Royal Perth Hospital Medical Research Foundation, the Fremantle Hospital Medical Research Foundation, and the Food Allergy and Anaphylaxis Network. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2013
American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 132 - N° 6
P. 1457 - dicembre 2013 Ritorno al numero
Articolo precedente
- Anaphylaxis: Clinical features and mediator release patterns
- Peter Vadas, Gary Liss
- Human basophils lack the capacity to drive memory CD4+ T cells toward the IL-22 response
- Meenu Sharma, Srini V. Kaveri, Jagadeesh Bayry
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?